Biolojic Design Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
69
- Latest Deal Type
-
Debt
- Latest Deal Amount
-
$1.25M
- Investors
-
4
Biolojic Design General Information
Description
Developer of a computational biology and artificial intelligence platform designed to transform antibodies into intelligent medicines. The company's platform offers machine learning, multibody capability, epitope-specific engineering, programmable functional switches, multispecific symmetrical IgG, and logic gate execution, enabling biopharmaceutical companies to program antibodies to adapt to changing biological situations.
Contact Information
Website
biolojic.comCorporate Office
- Hamada street 12
- Post Office Box 80
- Rehovot 7670316
- Israel
Corporate Office
- Hamada street 12
- Post Office Box 80
- Rehovot 7670316
- Israel
Biolojic Design Timeline
Biolojic Design Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Debt - General | 30-Jun-2025 | $1.25M | Completed | Generating Revenue | ||
| 7. Debt - General | 31-Mar-2025 | Completed | Generating Revenue | |||
| 6. Debt - General | 30-Jun-2023 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 01-Jan-2023 | Completed | Clinical Trials - Phase 1 | |||
| 4. Secondary Transaction - Private | Completed | Clinical Trials - Phase 1 | ||||
| 3. Equity Crowdfunding | 12-Jan-2021 | Completed | Clinical Trials - Phase 1 | |||
| 2. Later Stage VC (Series A) | 02-Jul-2018 | $11M | $15.2M | Completed | Clinical Trials - Phase 1 | |
| 1. Angel (individual) | 27-Aug-2014 | $4.15M | $4.15M | Completed | Pre-Clinical Trials |
Biolojic Design Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preferred B | ||||||||
| Preferred A1 | ||||||||
| Preferred A | 13,000 | $0.010000 | $83.21 | $83.21 | 1x | $83.21 | 10.44% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Biolojic Design Patents
Biolojic Design Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025253250-A1 | Engineered trop2/nectin4 dual binding antibodies and uses thereof | Pending | 02-Jun-2024 | ||
| WO-2025250701-A1 | Anti-tumor necrosis factor receptor 2 (tnfr2) antibodies and methods of use | Pending | 28-May-2024 | ||
| US-20260132195-A1 | Anti-il-2 antibody combinations and methods of use thereof | Pending | 04-Jan-2024 | ||
| US-20260183390-A1 | Anti-il-2 antibody combinations and methods of use thereof | Pending | 10-Nov-2022 | ||
| US-20260207741-A1 | Anti-il-2 antibody combinations and methods of use thereof | Pending | 10-Nov-2022 | A61K39/3955 |
Biolojic Design Signals
Biolojic Design Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Western Technology Investment | Venture Capital | Minority | ||
| aMoon Fund | Venture Capital | Minority | ||
| OurCrowd | Venture Capital | Minority | ||
| Angel (individual) | Minority |
Biolojic Design Investments (1)
Biolojic Design’s most recent deal was a Early Stage VC with Aulos for . The deal was made on 10-Aug-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Aulos | 10-Aug-2023 | Early Stage VC | Drug Discovery |
Biolojic Design FAQs
-
When was Biolojic Design founded?
Biolojic Design was founded in 2009.
-
Where is Biolojic Design headquartered?
Biolojic Design is headquartered in Rehovot, Israel.
-
What is the size of Biolojic Design?
Biolojic Design has 69 total employees.
-
What industry is Biolojic Design in?
Biolojic Design’s primary industry is Drug Discovery.
-
Is Biolojic Design a private or public company?
Biolojic Design is a Private company.
-
What is Biolojic Design’s current revenue?
The current revenue for Biolojic Design is .
-
How much funding has Biolojic Design raised over time?
Biolojic Design has raised $32.8M.
-
Who are Biolojic Design’s investors?
Western Technology Investment, aMoon Fund, OurCrowd, and have invested in Biolojic Design.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process